Pyxis Oncology CEO to participate in upcoming investor conferences
Pyxis Oncology said Tom Civik, interim CEO and director, will participate in upcoming investor conferences, including a fireside discussion.
BOSTON, Sept.
01, 2026 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc.
NASDAQ:PYXS, a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that Tom Civik, Interim Chief Executive Officer and Director of Pyxis Oncology, will participate in fireside…